PulmoLOR® - easy and free breath!

Composition of active ingredients: 

5 ml suspension  contains 30 mg of  the ambroxol hydrochlorid
and 5 mg of the loratadine

Dosage form: 

60 ml bottle of the powder for the oral suspension
with a measured glass on the lid, in a carton package
 

  • Tested combination of ambroxol and loratadine
  • Suppressing  the  cough  symptoms in prone to allergies people
  • Effective in case of the respiratory diseases with spastic and allergic component
Indications: 
Adults
Children from 6 years

Add boiled cooled water to the mark on the bottle and shake well.

Shake well before each use.

Administration and Dosages

For adults and children over 12 years: take 5 ml 2 times a day after meal.

Do not take more than 14 days without asking your doctor.

If the symptoms persist or intensify please consult a doctor.

Pharmacotherapeutic group

Medicine for cold and flu treatment.  Expectorants, except for combination products which comprise antitussives. ATC R 05S

Pharmacological properties

Pulmolor® has a strong expectorant effect, softens and soothes dry cough, breathing easier, normalizes the secretion of bronchial mucus, expectoration of sputum improves, reduces airway inflammation, has antipruritic  effect,  relieves spasm of smooth muscles of the bronchi and the swelling of tissues, including the nasal mucosa, throat, sinuses and respiratory tract, reduces the permeability of capillaries, eliminates nasal congestion, runny nose, watery eyes, sneezing, itching of the palate and nose, red eyes.

Ambroxol hydrochloride – mucolytic, expectorant ingredient with a strong expectorant, anti-inflammatory, immunomodulatory, anti-oxidant and a slight antitussive effect. It stimulates serous cells of glands of bronchial mucosa, increases the amount of mucous secretion, and thus changes the disturbed ratio of serous and mucous components. Normalizing sputum rheology, reducing its viscosity and adhesive properties.

Directly stimulating  the motor activity of ciliated epithelium of bronchi, prevents its sticking and improves mucociliary phlegm evacuation. Ambroxol increases the concentration of surfactant in the lungs and prevents its destruction in pneumocytes.
Ambroxol does not cause bronchial obstruction, but rather improves the respiratory function. It is proved that the drug reduces muscle hyperreactivity of the bronchi of patients with asthma. Ambroxol has anti-inflammatory effect, antioxidant properties, stimulates local immunity and the resumption of natural surfactant layer. Reducing cough and phlegm significantly.
Loratadine - selective blocker of peripheral H1-receptors prolonged action without a central sedation. It has anti-allergic effect, relieves spasm of bronchial smooth muscle, reduces the sensitivity of the bronchi to histamine, eliminates dry cough allergic etiology, reduces the permeability of capillaries, eliminates tissue swelling, runny nose, watery eyes, sneezing, itching of the palate and nose, red eyes. It prevents the development and facilitates the allergic reactions.

To obtain full information please see the Patient Leaflet Information. 

Indications

Symptomatic therapy of acute and chronic respiratory diseases with an allergic component, related to violation of bronchial secretions and loosening mucus disposal:

  • acute and chronic bronchitis;
  • chronic obstructive pulmonary disease;
  • pneumonia

In ENT practice in order to liquefy secretions and reduce swelling appoint:

  • rhinitis, including allergic;

Complex treatment:

  • sinusitis,
  • otitis.

Contraindications

Individual hypersensitiveness to any of the medicine ingredients.

To obtain full information please see the Patient Leaflet Information.

The simultaneous use PulmoLOR® with antibiotics is preferable as PulmoLOR® increases the concentration of antibiotic in lungs and thus improves the course of respiratory diseases of bacterial lung infections.

Before applying the skin test reactivity should stop taking the drug for 48 hours.

The product contains lactose, therefore patients with rare hereditary meets galactose intolerance, Lapp lactose deficiency or malabsorption of glucose and / or galactose is not recommended to take the drug. PulmoLOR®, powder for oral suspension is not used for phenylketonuria patients, because aspartame contained in the composition.

5 ml of the suspension contains 1.2 g sucrose, which should be considered in the total number of received sucrose per day to patients with diabetes and a diet low in sugar.

Do not take the medicine if you are pregnant or breast feeding.

Store in the original package below +25°С. To store 14 days at a temperature of 2 ° to 8 ° C after preparing the suspension.  

Keep out of the reach of children.

R.S. MOH  of  Ukraine № UA 10378/01/01; UA/10378/02/01 of 17.11.2014